<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412019001200005</article-id>
<article-id pub-id-type="doi">10.24245/gom.v87i12.3400</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Concentración sanguínea de troponina I en pacientes embarazadas sin y con preeclampsia severa]]></article-title>
<article-title xml:lang="en"><![CDATA[Troponin I blood concentration in pregnant patients without and with severe preeclampsia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vázquez-Rodríguez]]></surname>
<given-names><![CDATA[Juan Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Centro Médico Nacional La Raza Hospital de Ginecología y Obstetricia 3]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2019</year>
</pub-date>
<volume>87</volume>
<numero>12</numero>
<fpage>807</fpage>
<lpage>813</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412019001200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412019001200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412019001200005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO:  Comparar la concentración sanguínea de troponina I en pacientes embarazadas sin y con preeclampsia severa.  MATERIALES Y MÉTODOS:  Estudio prospectivo y transversal efectuado en pacientes de una unidad médica de alta especialidad en Ginecología y Obstetricia de la Ciudad de México admitidas entre los meses de enero a mayo de 2019. Criterio de inclusión: pacientes de cualquier edad y paridad con más de 20 semanas de embarazo. Criterio de exclusión: mujeres con enfermedades previas que pudieran condicionar daño miocárdico. Para cuantificar la troponina I a todas se les tomó sangre venosa. El valor normal de la troponina I está entre 0 y 0.4 ng/mL. Se les tomó un electrocardiograma y una radiografía de tórax. Los reportes de ambos grupos se compararon. Se utilizó estadística descriptiva y prueba t de Student pareada.  RESULTADOS:  71 mujeres reunieron los criterios de inclusión y se dividieron en dos grupos: 37 pacientes sin preeclampsia (grupo A) y 34 con preeclampsia (grupo B). La concentración sanguínea de la troponina I del grupo A fue 0.05 ± 0.008 ng/mL y del grupo B: 0.05 ± 0.02 ng/mL (p = 0.30). En el grupo B se encontraron alteraciones electrocardiográficas en 14.7% (n = 5) cuyos valores de troponina I fueron normales. La radiografía del tórax fue normal en 100%.  CONCLUSIONES:  La concentración sanguínea de troponina I en pacientes embarazadas sin y con preeclampsia severa resultó normal, incluidas las 5 mujeres con preeclampsia y alteraciones electrocardiográficas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE:  To compare the blood concentration of Troponin I (TI) in pregnant patients without and with severe preeclampsia (SP).  MATERIALS AND METHODS:  Prospective, cross-sectional study, conducted in patients of a medical unit of high specialty of gynecology and obstetrics of Mexico City admitted in the period from January to May of the year 2019. Patients of any age and parity with pregnancy &gt; 20 weeks were selected. Those with previous diseases that may condition myocardial damage were excluded. Venous blood was taken to quantify TI using the &#8220;Triage Cardiac Panel&#8221;® device of the Biosite® brand that runs an indirect immunofluorescence program coupled to a reader called &#8220;Triage Meter&#8221;®. For this test the normal value of TI is 0 to 0.4 ng/mL. An electrocardiogram and a chest X-ray were also performed. The results of both groups were compared. Descriptive statistics and the paired Student&amp;apos;s T test were used.  RESULTS:  71 women met the selection criteria. Two groups were formed: 37 patients without preeclampsia (group A) and 34 women with PS (group B). The blood concentration of TI in group A was 0.05 ± 0.008 ng / ml and in group B 0.05 ± 0.02 ng/mL (p = 0.30). In group B electrocardiographic abnormalities were found in 14.70% (5 cases) whose TI values were normal. Chest x-ray was normal in 100%.  CONCLUSIONS:  the blood concentration of TI in pregnant patients without and with PS was normal, including 5 preeclamptic women with electrocardiographic abnormalities.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Troponina I]]></kwd>
<kwd lng="es"><![CDATA[embarazo]]></kwd>
<kwd lng="es"><![CDATA[daño miocárdico]]></kwd>
<kwd lng="es"><![CDATA[triage cardiaco]]></kwd>
<kwd lng="es"><![CDATA[inmunofluorescencia indirecta]]></kwd>
<kwd lng="es"><![CDATA[preeclampsia]]></kwd>
<kwd lng="es"><![CDATA[anormalidades electrocardiográficas]]></kwd>
<kwd lng="en"><![CDATA[Troponin I]]></kwd>
<kwd lng="en"><![CDATA[Pregnancy]]></kwd>
<kwd lng="en"><![CDATA[Condition myocardial]]></kwd>
<kwd lng="en"><![CDATA[Triage cardiac]]></kwd>
<kwd lng="en"><![CDATA[Indirect immunofluorescence]]></kwd>
<kwd lng="en"><![CDATA[Pre-Eclampsia]]></kwd>
<kwd lng="en"><![CDATA[Electrocardiographic abnormalities]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García de la Villa]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor de la troponina I cardiaca como prueba diagnóstica en el estudio del dolor torácico]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>1998</year>
<volume>51</volume>
<page-range>122-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meráz-Soria]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilidad de la determinación cualitativa de la troponina I y CPK-isoenzima mb en los síndromes coronarios agudos]]></article-title>
<source><![CDATA[Arch Cardiol Mex]]></source>
<year>2006</year>
<volume>76</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>37-46</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mair]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponinas I and T for acute myocardial infarction]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>1995</year>
<volume>41</volume>
<page-range>1266-72</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction]]></article-title>
<source><![CDATA[Ann Clin Lab Sci]]></source>
<year>1996</year>
<volume>26</volume>
<page-range>291-300</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Georges]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Time course of troponin I, myoglobin, and cardiac enzyme release after electrical cardioversion]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>1996</year>
<volume>1</volume>
<page-range>825-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[ACOG Practice Bulletin No: 202 Gestational Hypertension and Preeclampsia]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2019</year>
<volume>133</volume>
<page-range>e1-e25</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barton]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endomyocardial ultrastructural findings in preeclampsia]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>1991</year>
<page-range>165</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Guía de Práctica Clínica</collab>
<source><![CDATA[Actualización 2017. Prevención, Diagnóstico y Tratamiento de la preeclampsia en el segundo y tercer nivel de atención]]></source>
<year>2017</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cambronero]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarkers of pathophysiology in hypertrophic cardiomyophaty implications for clinical management and prognosis]]></article-title>
<source><![CDATA[European Heart J]]></source>
<year>2009</year>
<volume>30</volume>
<page-range>139-51</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiac Troponin I in pre-eclampsia and gestational hypertension]]></article-title>
<source><![CDATA[BJOG]]></source>
<year>2000</year>
<volume>107</volume>
<page-range>1417-20</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pasupathi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women]]></article-title>
<source><![CDATA[Bangladesh Med Res Counc Bull]]></source>
<year>2010</year>
<volume>36</volume>
<page-range>4-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beigi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High Troponin I level among patients with severe preeclampsia]]></article-title>
<source><![CDATA[Life Sci J]]></source>
<year>2013</year>
<volume>10</volume>
<numero>^s11s</numero>
<issue>^s11s</issue>
<supplement>11s</supplement>
<page-range>81-3</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyna-Villasmil]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Troponina I en preeclampsia y eclampsia]]></article-title>
<source><![CDATA[Progr Obstet Ginecol]]></source>
<year>2015</year>
<volume>58</volume>
<page-range>393-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cot]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiac Troponin I levels in patients with severe preeclampsia and effect of magnesium sulfate treatment on cardiac Troponin I levels S.E.E.A.H]]></article-title>
<source><![CDATA[Tip Bülteni]]></source>
<year>2016</year>
<volume>50</volume>
<page-range>26-32</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sprawka]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Troponin I levels in mild and severe preeclampsia]]></article-title>
<source><![CDATA[AJOG]]></source>
<year>2008</year>
<numero>^sS174</numero>
<issue>^sS174</issue>
<supplement>S174</supplement>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Joyal]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Troponin I levels in patients with preeclampsia]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2007</year>
<volume>120</volume>
<page-range>819</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
